title: Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.
abstract: Transforming growth factor beta (TGF-beta) is a master regulator of autocrine and paracrine signaling pathways between a tumor and its microenvironment. Decreased expression of TGF-beta type II receptor (TbetaRII) in stromal cells is associated with increased tumor metastasis and shorter patient survival. In this study, SILAC quantitative proteomics was used to identify differentially externalized proteins in the conditioned media from the mammary fibroblasts with or without intact TbetaRII. Over 1000 proteins were identified and their relative differential levels were quantified. Immunoassays were used to further validate identification and quantification of the proteomic results. Differential expression was detected for various extracellular proteins, including proteases and their inhibitors, growth factors, cytokines, and extracellular matrix proteins. CXCL10, a cytokine found to be up-regulated in the TbetaRII knockout mammary fibroblasts, is shown to directly stimulate breast tumor cell proliferation and migration. Overall, this study revealed hundreds of specific extracellular protein changes modulated by deletion of TbetaRII in mammary fibroblasts, which may play important roles in the tumor microenvironment. These results warrant further investigation into the effects of inhibiting the TGF-beta signaling pathway in fibroblasts because systemic inhibition of TGF-beta signaling pathways is being considered as a potential cancer therapy.
authors.affiliation: Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA. baogang.j.xu@vanderbilt.edu
authors.forename: Baogang J
authors.initials: BJ
authors.lastname: Xu
authors.forename: Wenwei
authors.initials: W
authors.lastname: Yan
authors.forename: Bojana
authors.initials: B
authors.lastname: Jovanovic
authors.forename: Angel Q
authors.initials: AQ
authors.lastname: An
authors.forename: Nikki
authors.initials: N
authors.lastname: Cheng
authors.forename: Mary E
authors.initials: ME
authors.lastname: Aakre
authors.forename: Yajun
authors.initials: Y
authors.lastname: Yi
authors.forename: Jimmy
authors.initials: J
authors.lastname: Eng
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Link
authors.forename: Harold L
authors.initials: HL
authors.lastname: Moses
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D002465:Cell Movement; D049109:Cell Proliferation; D005347:Fibroblasts / Q000737:chemistry* / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000737:chemistry* / Q000166:cytology / Q000378:metabolism; D051379:Mice; D017346:Protein Serine-Threonine Kinases / Q000172:deficiency / Q000378:metabolism; D020543:Proteome / Q000032:analysis* / Q000378:metabolism; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000172:deficiency / Q000378:metabolism; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000378:metabolism*
chemical_list: D020543:Proteome; D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II
references.citation: Oncogene. 2005 Jul 28;24(32):5053-68
references.pmid: 15856015
references.citation: Proteomics. 2010 Mar;10(5):1029-39
references.pmid: 20049865
references.citation: Nat Cell Biol. 2007 Dec;9(12):1392-400
references.pmid: 18037882
references.citation: Nat Genet. 2001 Oct;29(2):117-29
references.pmid: 11586292
references.citation: Curr Opin Genet Dev. 2008 Feb;18(1):27-34
references.pmid: 18282701
references.citation: Science. 2004 Feb 6;303(5659):848-51
references.pmid: 14764882
references.citation: J Clin Invest. 2005 Apr;115(4):1068-81
references.pmid: 15761501
references.citation: J Proteome Res. 2010 Jan;9(1):545-55
references.pmid: 19924834
references.citation: Anticancer Res. 2003 Sep-Oct;23(5A):3899-904
references.pmid: 14666694
references.citation: J Exp Med. 1993 Jun 1;177(6):1809-14
references.pmid: 8496693
references.citation: Sci STKE. 2005 Jan 18;2005(267):pl2
references.pmid: 15657263
references.citation: Immunol Lett. 2004 Mar 29;92(1-2):171-8
references.pmid: 15081542
references.citation: J Proteome Res. 2010 Feb 5;9(2):1129-37
references.pmid: 20050688
references.citation: Genesis. 2002 Feb;32(2):73-5
references.pmid: 11857781
references.citation: EMBO J. 2000 Sep 1;19(17):4817-26
references.pmid: 10970872
references.citation: Breast Cancer Res Treat. 1992;22(1):21-9
references.pmid: 1421420
references.citation: Eur J Cancer. 2007 Sep;43(13):1895-904
references.pmid: 17624760
references.citation: Methods Mol Biol. 2008;424:101-11
references.pmid: 18369856
references.citation: Cancer Res. 2001 Dec 15;61(24):8601-10
references.pmid: 11751371
references.citation: Annu Rev Physiol. 1993;55:131-53
references.pmid: 8466170
references.citation: J Exp Med. 2001 Mar 19;193(6):727-40
references.pmid: 11257139
references.citation: Annu Rev Pathol. 2006;1:119-50
references.pmid: 18039110
references.citation: J Proteome Res. 2009 Aug;8(8):4135-43
references.pmid: 19469553
references.citation: Anal Chem. 2002 Oct 15;74(20):5383-92
references.pmid: 12403597
references.citation: Biosci Biotechnol Biochem. 1995 Feb;59(2):341-4
references.pmid: 7766036
references.citation: J Biol Chem. 2003 Jan 31;278(5):2969-76
references.pmid: 12433918
references.citation: Lab Invest. 1996 Jan;74(1):168-77
references.pmid: 8569179
references.citation: Cancer Treat Rev. 2008 Apr;34(2):122-36
references.pmid: 18162327
references.citation: Oncogene. 2007 Aug 30;26(40):5966-72
references.pmid: 17369847
references.citation: Nat Rev Cancer. 2006 May;6(5):392-401
references.pmid: 16572188
references.citation: Cancer Res. 1991 Sep 15;51(18):4978-85
references.pmid: 1893385
references.citation: J Cell Physiol. 1994 Jan;158(1):69-78
references.pmid: 7505280
references.citation: Eur J Biochem. 1990 Jul 5;190(3):445-62
references.pmid: 2197088
references.citation: Lab Invest. 1995 Sep;73(3):311-31
references.pmid: 7564264
references.citation: Mol Reprod Dev. 1997 Jan;46(1):71-4
references.pmid: 8981366
references.citation: Curr Opin Genet Dev. 2005 Feb;15(1):97-101
references.pmid: 15661539
references.citation: Cancer Res. 2006 Oct 1;66(19):9509-18
references.pmid: 17018607
references.citation: Int J Cancer. 1998 Jun 10;76(6):829-35
references.pmid: 9626349
references.citation: Genome Res. 2001 Sep;11(9):1463-8
references.pmid: 11544189
references.citation: J Immunol. 2001 Dec 1;167(11):6576-82
references.pmid: 11714827
references.citation: Nat Rev Cancer. 2006 Jul;6(7):506-20
references.pmid: 16794634
references.citation: Br J Cancer. 2007 Mar 26;96(6):903-11
references.pmid: 17342087
references.citation: Exp Biol Med (Maywood). 2004 Jan;229(1):1-11
references.pmid: 14709771
references.citation: Oncogene. 2002 Mar 28;21(14):2245-52
references.pmid: 11948407
references.citation: Cancer Res. 2006 Aug 1;66(15):7701-7
references.pmid: 16885372
references.citation: J Endocrinol. 2005 Jul;186(1):165-78
references.pmid: 16002546
references.citation: Cancer Res. 2007 Apr 1;67(7):3396-405
references.pmid: 17409450
references.citation: Crit Rev Oncol Hematol. 2008 Apr;66(1):1-9
references.pmid: 17913510
references.citation: Nat Biotechnol. 2001 Mar;19(3):242-7
references.pmid: 11231557
references.citation: Ann N Y Acad Sci. 1993 Nov 30;698:131-5
references.pmid: 8279750
references.citation: Nat Biotechnol. 2001 Oct;19(10):946-51
references.pmid: 11581660
references.citation: Mol Cell Proteomics. 2009 Dec;8(12):2746-58
references.pmid: 19776420
references.citation: Cytokine Growth Factor Rev. 1997 Sep;8(3):207-19
references.pmid: 9462486
references.citation: BMC Cancer. 2007 Aug 10;7:156
references.pmid: 17692120
references.citation: J Proteome Res. 2002 May-Jun;1(3):211-5
references.pmid: 12645897
references.citation: Cancer Res. 2007 May 15;67(10):4869-77
references.pmid: 17495323
references.citation: Endocr Relat Cancer. 2006 Jun;13(2):593-605
references.pmid: 16728585
references.citation: Cancer Lett. 2007 Jul 8;252(1):147-56
references.pmid: 17258390
references.citation: Lab Invest. 2001 Nov;81(11):1485-501
references.pmid: 11706057
references.citation: Circ Res. 2003 May 2;92(8):827-39
references.pmid: 12730128
references.citation: J Cell Biochem. 2007 Jul 1;101(4):851-61
references.pmid: 17486574
references.citation: Physiol Rev. 1996 Jan;76(1):69-125
references.pmid: 8592733
references.citation: Methods. 2005 Mar;35(3):274-90
references.pmid: 15722224
references.citation: Nat Biotechnol. 1999 Jul;17(7):676-82
references.pmid: 10404161
references.citation: Cell. 2005 Dec 16;123(6):985-7
references.pmid: 16360028
references.citation: Mol Cell Proteomics. 2002 May;1(5):376-86
references.pmid: 12118079
references.citation: J Clin Invest. 2009 Jun;119(6):1571-82
references.pmid: 19451693
references.citation: Mol Carcinog. 1993;7(4):207-11
references.pmid: 8352880
references.citation: Cancer Cell. 2003 Jun;3(6):531-6
references.pmid: 12842082
references.citation: J Endocrinol. 2002 Oct;175(1):19-31
references.pmid: 12379487
references.citation: Cancer Res. 2006 Jan 1;66(1):259-66
references.pmid: 16397239
references.citation: Anal Chem. 2003 Sep 1;75(17):4646-58
references.pmid: 14632076
references.citation: Cardiovasc Res. 2004 Jul 1;63(1):87-97
references.pmid: 15194465
references.citation: J Proteome Res. 2009 Jan;8(1):380-9
references.pmid: 19012429
references.citation: Cancer Biol Ther. 2006 Dec;5(12):1640-6
references.pmid: 17106243
references.citation: Nat Rev Cancer. 2001 Oct;1(1):46-54
references.pmid: 11900251
references.citation: Nat Rev Cancer. 2004 Jan;4(1):71-8
references.pmid: 14708027
references.citation: Int J Cancer. 2007 May 15;120(10):2086-95
references.pmid: 17290405
references.citation: Endocr Rev. 1995 Apr;16(2):143-63
references.pmid: 7540132
references.citation: PLoS One. 2006 Dec 20;1:e32
references.pmid: 17183660
references.citation: Cancer Res. 2000 Mar 1;60(5):1254-60
references.pmid: 10728684
references.citation: J Clin Pathol. 2005 Apr;58(4):361-6
references.pmid: 15790698
references.citation: Breast Cancer Res. 2002;4(6):231-9
references.pmid: 12473169